about
Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being in...
Read More
4.75
-0.11
(-2.26%)
480.8K
XNAS Volume
XNAS 18 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..